The development of DNA-biochips for rational prescribing of psychologists (Q11681): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Created claim: summary (P836): The aim of the project is to develop a new DNA-biochip for a streamlined psychologist for patients with psychiatric illness, thereby bringing benefits not only to the patient but to reducing the costs of health insurance companies. The project will benefit from a safer and more effective psychopharmacy, leading to more successful pharmacotherapy, increasing the comfort of the patient in the form of positive therapy, and reducing the costs of the...)
(‎Removed claims)
Property / EU contribution
7,740,698.73 Czech koruna
Amount7,740,698.73 Czech koruna
UnitCzech koruna
 
Property / EU contribution: 7,740,698.73 Czech koruna / rank
Normal rank
 
Property / EU contribution
309,627.94920000003 Euro
Amount309,627.94920000003 Euro
UnitEuro
 
Property / EU contribution: 309,627.94920000003 Euro / rank
Preferred rank
 
Property / EU contribution: 309,627.94920000003 Euro / qualifier
exchange rate to Euro: 0.04 Euro
Amount0.04 Euro
UnitEuro
 
Property / EU contribution: 309,627.94920000003 Euro / qualifier
point in time: 10 January 2020
Timestamp+2020-01-10T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
 

Revision as of 16:43, 3 March 2020

Project in Czech Republic financed by DG Regio
Language Label Description Also known as
English
The development of DNA-biochips for rational prescribing of psychologists
Project in Czech Republic financed by DG Regio

    Statements

    0 references
    11,073,961.0 Czech koruna
    0 references
    442,958.44 Euro
    10 January 2020
    0 references
    69.8999999187283 percent
    0 references
    31 October 2020
    0 references
    ESSENCE LINE, s.r.o.
    0 references
    0 references

    50°4'11.50"N, 14°22'51.56"E
    0 references

    50°4'6.46"N, 14°23'8.41"E
    0 references
    15000
    0 references
    15000
    0 references
    Cílem projektu je vyvinout nový DNA-biochip pro racionalizovanou preskripci psychofarmak pro pacienty s psychiatrickým onemocněním a tím přinést prospěch nejen pacientovi, ale snížit náklady zdravotních pojišťoven. Přínosem projektu bude bezpečnější a efektivnější preskripce psychofarmak, což povede k úspěšnější farmakoterapii, zvýší komfort pacienta v podobě pozitivní terapie a sníží náklady na neefektivně aplikovaná psychofarmaka a negativní dopady na pacienta. a. (Czech)
    0 references
    The aim of the project is to develop a new DNA-biochip for a streamlined psychologist for patients with psychiatric illness, thereby bringing benefits not only to the patient but to reducing the costs of health insurance companies. The project will benefit from a safer and more effective psychopharmacy, leading to more successful pharmacotherapy, increasing the comfort of the patient in the form of positive therapy, and reducing the costs of the inefficiently applied psychopharmacy and the negative impacts on the pacemaker. (English)
    0 references

    Identifiers

    CZ.01.1.02/0.0/0.0/17_107/0012433
    0 references